Zileuton, a leukotriene synthesis inhibitor in the management of chronic asthma. Clinical pharmacokinetics and safety.
Dubé
L M
LM
Abbott Laboratories, Abbott Park, IL 60064-3500, USA. Louise.Dube@Abbott.com
Swanson
L J
LJ
Awni
W
W
D001249:Asthma / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D020024:Leukotriene Antagonists / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D013997:Time Factors
D020024:Leukotriene Antagonists; C063449:zileuton; D006918:Hydroxyurea